Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Lawmaker ‘deeply concerned’ over $250M HHS contract for coronavirus-related PR work

Rep. Frank Pallone Jr., D-N.J., worries the agency is using taxpayer funds to fuel the commander-in-chief’s bid for a second term. 

Alleged Stark violations, kickbacks to cost hospital $50M

A 223-bed acute care institution with a medical staff of nearly 300 physicians has agreed to pay $50 million over allegations it deliberately submitted ineligible claims to Medicare and profited handsomely by these actions.  

Thumbnail

4 hurdles thwarting AI from conquering clinical practice

AI will not earn a place in the daily practice of medicine until its developers definitively answer some pressing questions on fitness and appropriateness.

Researchers clarify: Don’t dismiss the neck gaiter as a facemask failure

Remember the Duke study that seemed to suggest a neck gaiter can spread more COVID than no mask at all? Its authors now say their findings were misconstrued. Gaiters may be OK after all.

Thumbnail

Standard operating procedures start chugging back to life at Medicare, Medicaid

As part of its Monday announcement, CMS released inspection guidance for state agencies and a toolkit for nursing homes.

Thumbnail

$66M to hospitalize 38 patients over 3 weeks—would you take that deal?

Responding swiftly to the COVID crisis this past spring, the city of Chicago imagined, built and began operating a nicely outfitted, high-capacity hospital in just three weeks and five days. That was the impressive part.

Search engines unequally inhospitable to antivaxxers

Privacy-first search engines brought back numerous sites when researchers entered the words vaccine and autism. Google turned up zero. Is that impressive—or glaring?

Debate over hybrid classrooms a signpost of back-to-school health troubles ahead

On its face, hybrid schooling appears a prudent compromise during the COVID-19 crisis. However, it’s awfully easy to find health and education experts crying Stop the madness.

Displaying 729 - 736 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup